STOCK TITAN

ACM Research, Inc. 8-K Filings

ACMR NASDAQ

Every 8-K that ACM Research, Inc. (ACMR) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow ACMR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ACMR filings page.

Rhea-AI Summary

ACM Research, Inc. (ACMR) furnished an English translation of an investor relations record from its operating subsidiary ACM Research (Shanghai), Inc., whose shares trade on the STAR Market of the Shanghai Stock Exchange. The record summarizes an August 14, 2026 earnings conference call.

ACM Shanghai reported that newly signed orders in the first half of 2026 increased by 105% year-over-year, with growth across memory, logic and advanced packaging. Management highlighted strong order momentum in electroplating, cleaning and advanced packaging equipment, including a major technological breakthrough in high-temperature SPM cleaning using a proprietary nozzle that achieved fewer than 15 particles at 15 nm, and expects cumulative shipments of high-temperature single-wafer SPM systems to exceed 20 systems by the end of 2026.

New panel-level electroplating systems support panel sizes of 310 × 310 mm, 510 × 515 mm and 600 × 600 mm, with a 510 × 515 mm production system scheduled for delivery in the first quarter of 2027 and a 310 × 310 mm evaluation system planned for delivery by the end of 2026. ACM Shanghai stated it expects overall gross margin to remain in the 42%–48% range, subject to quarterly product-mix fluctuations, and described ongoing furnace-equipment R&D and customer qualifications. The disclosure is furnished, not filed, under U.S. securities laws.

Rhea-AI Summary

ACM Research reported strong results for the quarter ended June 30, 2026. Revenue was $292.9 million, up 36.0% year over year, driven mainly by ECP, furnace and other technologies, and advanced packaging, while single-wafer cleaning and Tahoe tools declined. GAAP gross margin was 46.0%, above the mid-point of the company’s long-term 42%–48% target range.

GAAP income from operations rose to $49.7 million, with operating margin of 17.0%. Net income attributable to ACM Research was $89.0 million, and GAAP diluted EPS was $1.23. On a non-GAAP basis, net income attributable to ACM Research was $44.5 million and diluted EPS was $0.61.

Cash and cash equivalents, restricted cash and short-term time deposits totaled $1.36 billion at June 30, 2026, with net cash of $1.0 billion. Total shipments were $281.5 million, up 36.4% year over year. Management raised its 2026 revenue outlook to $1.125–$1.175 billion and is targeting 25%–30% full-year growth while working toward a long-term revenue target of $4 billion.

Rhea-AI Summary

ACM Research, Inc. furnished an 8-K sharing a June 2026 investor Q&A from its listed subsidiary ACM Research (Shanghai), Inc. The Record notes that newly signed orders at ACM Shanghai rose 65% year-over-year in the first quarter of 2026 and that full-year 2026 revenue guidance is maintained at RMB 8.20–8.80 billion.

Management highlights strong demand for cleaning and electroplating tools, with electroplating systems representing about 30% of newly signed orders year-to-date. They describe how the Lingang mini-line is accelerating R&D, process validation and customer qualification, supporting faster adoption of new products such as PECVD and furnace systems.

The Q&A also outlines a long-term revenue target of USD 4 billion, split between USD 1.6 billion from overseas markets and USD 2.4 billion from mainland China, and indicates that once both Lingang Plants A and B are fully operational, combined annual output value is expected to reach roughly RMB 20 billion.

Rhea-AI Summary

ACM Research, Inc. reported the results of its 2026 Annual Meeting of Stockholders held on June 10, 2026. Holders of Class A and Class B shares representing 135,814,497 votes, or 84.32% of total voting power, were present in person or by proxy, establishing a strong quorum.

Stockholders elected four directors to serve until the 2027 annual meeting: David H. Wang, Haiping Dun, Tracy Liu, and Charles Pappis. Each nominee received over 117 million votes "for," with broker non-votes reported separately.

Stockholders also ratified the appointment of Ernst & Young Hua Ming LLP as independent auditor for the fiscal year ending December 31, 2026, with 135,717,653 votes for, 40,635 against, and 56,209 abstaining.

Rhea-AI Summary

ACM Research, Inc. reports that its operating subsidiary ACM Research (Shanghai), Inc. has board approval to pursue an H share offering and listing on the Main Board of the Hong Kong Stock Exchange. ACM Shanghai plans to issue H shares representing no more than 7% of its total issued share capital upon completion of the offering, with an over-allotment option of up to 15% of the initial H shares.

The H shares will be ordinary shares with a par value of RMB 1.00, offered through a Hong Kong public offering and international placing. Net proceeds are intended for product development, strengthening research and development, expanding global market and service capabilities, general working capital, and repayment of bank loans.

The plan, along with extensive related governance and structural changes, has been unanimously approved by ACM Shanghai’s board but remains subject to shareholder approval and multiple regulatory filings and clearances in mainland China and Hong Kong. The resolution for the H share listing would be valid for 24 months from shareholder approval, with automatic extension until completion of the listing and any over-allotment exercise if approvals are obtained within that period.

Rhea-AI Summary

ACM Research, Inc. reported that its subsidiary ACM Research (Shanghai), Inc. held an investor earnings conference call on May 14, 2026, in connection with its listing on the STAR Market of the Shanghai Stock Exchange. Management said new orders signed in the first quarter of 2026 grew 65% year over year, which they described as a favorable foundation for future revenue. They explained that order delivery and revenue recognition depend on installation, commissioning, inspection and customer acceptance, with an average delivery cycle of about six months.

ACM Shanghai highlighted progress in its high-temperature single-wafer SPM cleaning tools, stating these can control down to 15 particles at the 15 nm level and avoid periodic DI water cleaning through a patented nozzle design. Management plans to further improve performance toward 13 nm particle sizes and expects to deliver more than 20 medium- to low-temperature and high-temperature SPM tools to multiple customers in 2026. The company emphasized forward-looking risks, including order timing, qualification and acceptance of tools, supply constraints, market acceptance, competition and global regulatory and macroeconomic conditions.

Rhea-AI Summary

ACM Research, Inc. completed a registered direct stock offering of 2,884,615 shares of Class A common stock at $52.00 per share under an effective Form S-3 shelf registration. The transaction closed on May 15, 2026, and the company received approximately $149,849,980 in net proceeds after estimated expenses.

Rhea-AI Summary

ACM Research, Inc. entered into a Securities Purchase Agreement with U.S. institutional investors for a registered direct offering of 2,884,615 shares of Class A common stock at $52.00 per share. Closing is expected on or about May 15, 2026, subject to customary conditions.

The company expects net proceeds of approximately $149,849,980, which it plans to use, together with existing cash and cash equivalents, for U.S. and global expansion and general corporate purposes. ACM Research agreed to a six-month lock-up on its Class A common stock and certain other securities, subject to specified exceptions.

Rhea-AI Summary

ACM Research, Inc. reported first-quarter 2026 revenue of $231.3 million, up 34.2% year over year, driven by electrochemical plating, furnace and advanced packaging tools. Shipments reached $240.7 million, up 53.6%, supporting future revenue.

GAAP income from operations increased to $36.2 million and operating margin improved to 15.6%, while GAAP net income attributable to ACM Research was $17.3 million. Non-GAAP net income was $24.3 million, with non-GAAP diluted EPS of $0.34.

ACM ended March 31, 2026 with $1.25 billion in cash, restricted cash and short-term time deposits and net cash of $924.2 million, helped by selling about 4.8 million ACM Shanghai shares for roughly $110 million in gross proceeds. Management maintained full-year 2026 revenue guidance of $1.08–$1.175 billion and emphasized momentum from new products and a proposed Hong Kong listing of ACM Shanghai.

Rhea-AI Summary

ACM Research, Inc. released an early look at its first quarter 2026 performance, projecting preliminary unaudited revenue of $225 million to $230 million, which would mean year-over-year growth of 31% to 33%. The company also expects preliminary total shipments of $233 million to $238 million, implying year-over-year growth of 49% to 52%.

For the full year 2026, ACM reaffirmed its revenue outlook in the range of $1.08 billion to $1.175 billion, representing expected growth of 20% to 30%. Management noted that actual first quarter results remain subject to quarter-end closing procedures and review by its independent registered public accounting firm.

Rhea-AI Summary

ACM Research, Inc. disclosed that its operating subsidiary, ACM Research (Shanghai), Inc., plans to issue overseas listed H shares and apply for listing on The Stock Exchange of Hong Kong Limited. ACM Shanghai is already listed on the Sci-Tech innovation board of the Shanghai Stock Exchange.

The proposed H share listing is intended to deepen strategic development, expand international markets, strengthen the capital base, attract and retain talent, and enhance competitiveness. It will not change ACM Shanghai’s controlling shareholder or actual controller, and remains at an early stage with specific terms still under discussion.

The proposal must be reviewed and approved by ACM Shanghai’s board and shareholders and also obtain filings or approvals from multiple regulators, including the China Securities Regulatory Commission, HKEX, and Hong Kong’s Securities and Futures Commission. The company highlights significant uncertainty about whether the listing will pass these procedures and ultimately be implemented.

Rhea-AI Summary

ACM Research, Inc. reports that its Shanghai subsidiary, ACM Research (Shanghai), Inc., has proposed a 2025 cash dividend of RMB 6.233 per 10 shares (inclusive of tax), subject to approval at its 2026 Annual General Meeting of Shareholders.

Based on 480,164,789 shares outstanding as of December 31, 2025 and after deducting 443,400 repurchased shares, ACM Shanghai plans a total cash dividend of RMB 299,010,341.76, equal to 21.42% of 2025 net profit attributable to shareholders. Including RMB 50,012,340.46 of share repurchases, total cash returns for 2025 would be RMB 349,022,682.22, or 25.00% of net profit. ACM Shanghai notes it continues to invest heavily in R&D and that its proposed payout will not materially affect operating cash flows.

Rhea-AI Summary

ACM Research, Inc. furnished an English translation of an investor relations call held by its majority-owned subsidiary ACM Research (Shanghai), Inc. on March 10, 2026. Management discussed 2025 performance, technology roadmap, overseas expansion and detailed financial targets for 2026.

ACM Shanghai expects 2026 revenue between RMB 8.2 billion and RMB 8.8 billion, targeting a gross margin of 42% to 48% and R&D spending at 14% to 19% of revenue. The company highlighted growth opportunities in panel-level packaging for AI chips, front-end track tools and PECVD systems.

Management emphasized localization of components, noting full domestic sourcing of non-standard parts and progress on key standard components. They stated that 2025 asset impairment provisions and recent component price movements are not expected to have a material adverse effect on ongoing operations, while reaffirming a constructive multi-year semiconductor industry outlook.

Rhea-AI Summary

ACM Research reported record 2025 revenue but weaker profitability. Full-year revenue reached $901.3 million, up 15.2% from 2024, with fourth-quarter revenue of $244.4 million, up 9.4%. Growth was driven by single-wafer cleaning, Tahoe and semi-critical tools, electrochemical plating, furnace technologies, and advanced packaging, services and spares.

Profitability softened as 2025 GAAP gross margin declined to 44.4% from 50.1%, and operating income fell to $109.4 million from $151.0 million. GAAP net income attributable to ACM Research, Inc. dipped to $94.1 million, with diluted EPS of $1.37 versus $1.53 a year earlier. The company ended 2025 with $1.13 billion in cash, restricted cash, and time deposits and net cash of $845.5 million, aided by a private offering at ACM Research (Shanghai), Inc. and a February 2026 sale of about 4.8 million ACM Shanghai shares for roughly $111 million.

Management is maintaining 2026 revenue guidance of $1.08 billion to $1.175 billion, implying 21–30% growth, and highlighted new tool shipments, expanding advanced packaging orders, and ongoing investment in an Oregon facility expected to begin operations in the second half of 2026.

Rhea-AI Summary

Research, Inc., through its controlling subsidiary ACMR US, completed an inquiry-based sale of 4,801,648 shares of Research (Shanghai), Inc. at RMB 160.00 (approximately $23.05) per share to 30 institutional investors.

After this transaction, the aggregate ownership of ACMR US and its concert parties in Shanghai decreased from 74.84% to 73.72%, a 1.00% reduction of Shanghai’s total share capital. Shanghai states there are no undisclosed operational risks or other material matters under applicable STAR Market listing rules, and the change does not alter its controlling shareholder or actual controller.

Rhea-AI Summary

ACM Research, Inc. reported that shares of its operating subsidiary, Research (Shanghai), Inc. are listed on the Sci-Tech innovation board (the STAR Market) of the Shanghai Stock Exchange. In line with STAR Market rules, the Shanghai subsidiary filed a Record of January 2026 Investor Relations Activity with the exchange.

The Shanghai Stock Exchange posted this investor relations record on January 29, 2026, and ACM Research furnished an unofficial English translation as Exhibit 99.1. The company emphasized that this information is being furnished, not filed, and is not incorporated by reference into its Securities Act filings.

Rhea-AI Summary

ACM Research, Inc. announced that its operating subsidiary, Research (Shanghai), Inc., has set a preliminary transfer price for a planned sale of 4,801,648 shares on the Shanghai Stock Exchange through an inquiry-based share transfer plan.

The preliminarily determined price is RMB 160.00 (approximately $23.05) per share, based on quotations from 38 institutional investors. The actual number of shares sold, sale prices, and aggregate proceeds may vary and are subject to market conditions, completion of settlement procedures in China, and other listed risks.

Rhea-AI Summary

Research, Inc. reported that its operating subsidiary, Research (Shanghai), Inc., has notified the Shanghai Stock Exchange that the company intends to sell 4,801,648 shares of the Shanghai subsidiary through an inquiry-based transfer plan. These shares represent about 1.34% of Research, Inc.’s ownership in the subsidiary and about 1% of the subsidiary’s total shares outstanding, each as of January 30, 2026. The company plans to use any sale proceeds for general corporate purposes, and notes that the actual number of shares sold and proceeds received will depend on market conditions and other factors.

Rhea-AI Summary

ACM Research, Inc. filed a current report to note that it has updated its 2025 revenue outlook and provided an initial revenue outlook for 2026. This update was communicated in a press release titled “ACM Research Updates 2025 Revenue Outlook and Provides Initial Outlook for 2026 Revenue,” which is included as an exhibit to the filing and incorporated by reference.

The report classifies this disclosure under results of operations and financial condition, signaling that management is sharing revised expectations for how the business may perform. The press release is furnished rather than filed, which affects how it is treated under securities law but not its informational value for understanding the company’s forward-looking views.

Rhea-AI Summary

ACM Research, Inc. (ACMR) reported that its operating subsidiary, ACM Research (Shanghai), Inc., which is listed on the STAR Market of the Shanghai Stock Exchange, filed a Record of November 2025 Investor Relations Activity with the Shanghai Stock Exchange. The exchange posted this record on November 19, 2025, and ACM has attached an unofficial English translation as Exhibit 99.1.

The company specifies that this information, including Exhibit 99.1, is being furnished rather than filed, meaning it is not subject to certain liability provisions of the U.S. securities laws and is not automatically incorporated by reference into other ACM Research filings.

Rhea-AI Summary

ACM Research, Inc. furnished an 8-K announcing it issued a press release with financial results for the third quarter of 2025. The press release, dated November 5, 2025, is included as Exhibit 99.1 and incorporated by reference.

The disclosure was made under Item 2.02 (Results of Operations and Financial Condition) and is designated as furnished, not filed under the Exchange Act. The filing also lists the company’s Class A common stock trading on Nasdaq under the symbol ACMR.

Rhea-AI Summary

ACM Research, Inc. filed an 8-K to furnish a press release announcing its preliminary unaudited revenue and shipment information for the third quarter of 2025. The press release, titled “ACM Research Announces Preliminary Unaudited Revenue and Shipments for the Third Quarter 2025,” is included as Exhibit 99.1 and incorporated by reference. The company notes that this information is being furnished under Item 2.02, meaning it is not deemed filed for liability purposes under Section 18 of the Exchange Act or automatically incorporated into other securities filings.

Rhea-AI Summary

ACM Research, Inc. filed a current report to let investors know it issued a press release on September 29, 2025. The release, titled “Research’s Operating Subsidiary Research (Shanghai) Provides Backlog Data,” comes from its Shanghai operating subsidiary and is attached to the report as an exhibit.

Rhea-AI Summary

Research, Inc. filed a current report to inform investors about a press release issued on September 24, 2025. The press release, titled “Research’s Operating Subsidiary Research (Shanghai) Announces Issuance Report on Private Offering of Ordinary Shares,” describes activity at the company’s Shanghai operating subsidiary related to a private offering of ordinary shares.

The full text of this press release is included as Exhibit 99.1 and incorporated by reference, and the filing also includes a cover page interactive data file as Exhibit 104.

Rhea-AI Summary

ACM Research, Inc. reported that its operating subsidiary, ACM Research (Shanghai), Inc., filed a Record of August 2025 Investor Relations Activity with the Shanghai Stock Exchange’s STAR Market. The Shanghai Stock Exchange posted this record on August 15, 2025.

The company furnished an unofficial English translation of this record as Exhibit 99.1 for investors who follow ACM Research’s activities in China. The information, including the exhibit, is being furnished rather than filed, meaning it is not subject to certain liability provisions under U.S. securities laws and is not automatically incorporated into other ACM Research securities filings.